Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge
Radboud University Nijmegen · Radboud University Medical Center · +20 more institutions
Abstract
Through a community-driven competition, the PANDA challenge provides a curated diverse dataset and a catalog of models for prostate cancer pathology, and represents a blueprint for evaluating AI algorithms in digital pathology.Artificial intelligence (AI) has shown promise for diagnosing prostate cancer in biopsies. However, results have been limited to individual studies, lacking validation in multinational settings. Competitions have been shown to be accelerators for medical imaging innovations, but their impact is hindered by lack of reproducibility and independent validation. With this in mind, we organized the PANDA challenge-the largest histopathology competition to date, joined by 1,290 developers-to…
Citation impact
- FWCI
- —
- Percentile
- —
- References
- 39
Authors
33- VDvan der Laak JCorresponding
Radboud University Nijmegen, Radboud University Medical Center
- CGCorrado GSCorresponding
Tampere University, Karolinska Institutet
- ARAllan RCorresponding
Google (United States)
- NKNagpal K
Karolinska Institutet
- ELEgevad L
Radboud University Nijmegen, Radboud University Medical Center
Topics & keywords
- Prostate cancer
- Grading (engineering)
- Medicine
- Confidence interval
- Medical physics
- Machine learning
- Artificial intelligence
- Prostate